PacBio reposted this
“Getting AAV-based gene therapies to the clinic requires speed and collaboration among many different parties. But it’s become clear that speed and collaboration are being held back by the lack of a common language and practices in dealing with AAV vectors,” said Claire Aldridge, Ph.D, chief strategy officer for Form Bio. “We see working with our partners at PacBio and bringing together leaders across academia and industry as a critical need in helping AAV-based gene therapies reach their fullest potential faster,” she added. https://hubs.li/Q02FgJwB0 #AAV #bestpractices #genetherapy #HiFisequencing #productcharacterization
